132 related articles for article (PubMed ID: 33905391)
1. Treatment of Cutaneous Squamous Cell Carcinoma In Situ With Curettage Followed by Topical Imiquimod 5% Cream.
Ondo AL; Kerner JD; Kerner JV; Ondo IP; Trainor P; Shanler SD
Dermatol Surg; 2021 May; 47(5):609-612. PubMed ID: 33905391
[TBL] [Abstract][Full Text] [Related]
2. Topical imiquimod therapy for basal and squamous cell carcinomas: a clinical experience.
Tillman DK; Carroll MT
Cutis; 2007 Mar; 79(3):241-8. PubMed ID: 17674590
[TBL] [Abstract][Full Text] [Related]
3. Topical Treatment of Cutaneous Squamous Cell Carcinoma in Situ and the Impact of Clinical Risk Factors and Positive Histologic Margins at the Time of Diagnosis.
Calley BJ; Fazio J; Banerjee A; Clark MA
Dermatol Surg; 2024 Mar; 50(3):219-223. PubMed ID: 38048273
[TBL] [Abstract][Full Text] [Related]
4. Surgery versus combined treatment with curettage and imiquimod for nodular basal cell carcinoma: One-year results of a noninferiority, randomized, controlled trial.
Sinx KAE; Nelemans PJ; Kelleners-Smeets NWJ; Winnepenninckx VJL; Arits AHMM; Mosterd K
J Am Acad Dermatol; 2020 Aug; 83(2):469-476. PubMed ID: 32320773
[TBL] [Abstract][Full Text] [Related]
5. Pilot study using topical imiquimod 5% cream in the treatment of nodular basal cell carcinoma after initial treatment with curettage.
Neville JA; Williford PM; Jorizzo JL
J Drugs Dermatol; 2007 Sep; 6(9):910-4. PubMed ID: 17941362
[TBL] [Abstract][Full Text] [Related]
6. A 36-month clinical experience of the effectiveness of curettage and imiquimod 5% cream in the treatment of basal cell carcinoma.
Tillman DK; Carroll MT
J Drugs Dermatol; 2008 Jan; 7(1 Suppl 1):s7-14. PubMed ID: 18277457
[TBL] [Abstract][Full Text] [Related]
7. Topical combination therapy for cutaneous squamous cell carcinoma in situ with 5-fluorouracil cream and imiquimod cream in patients who have failed topical monotherapy.
Ondo AL; Mings SM; Pestak RM; Shanler SD
J Am Acad Dermatol; 2006 Dec; 55(6):1092-4. PubMed ID: 17097406
[TBL] [Abstract][Full Text] [Related]
8. Imiquimod 5% cream monotherapy for cutaneous squamous cell carcinoma in situ (Bowen's disease): a randomized, double-blind, placebo-controlled trial.
Patel GK; Goodwin R; Chawla M; Laidler P; Price PE; Finlay AY; Motley RJ
J Am Acad Dermatol; 2006 Jun; 54(6):1025-32. PubMed ID: 16713457
[TBL] [Abstract][Full Text] [Related]
9. Rate of Recurrence of Lentigo Maligna Treated With Off-Label Neoadjuvant Topical Imiquimod, 5%, Cream Prior to Conservatively Staged Excision.
Donigan JM; Hyde MA; Goldgar DE; Hadley ML; Bowling M; Bowen GM
JAMA Dermatol; 2018 Aug; 154(8):885-889. PubMed ID: 29847610
[TBL] [Abstract][Full Text] [Related]
10. Treatment of cutaneous tumors with topical 5% imiquimod cream.
Alessi SS; Sanches JA; Oliveira WR; Messina MC; Pimentel ER; Festa Neto C
Clinics (Sao Paulo); 2009; 64(10):961-6. PubMed ID: 19841702
[TBL] [Abstract][Full Text] [Related]
11. Two cases of squamous cell carcinoma treated with topical imiquimod 5%.
Oster-Schmidt C
J Eur Acad Dermatol Venereol; 2004 Jan; 18(1):93-5. PubMed ID: 14678542
[TBL] [Abstract][Full Text] [Related]
12. Imiquimod 5% cream following curettage without electrodesiccation for basal cell carcinoma: preliminary report.
Rigel DS; Torres AM; Ely H
J Drugs Dermatol; 2008 Jan; 7(1 Suppl 1):s15-6. PubMed ID: 18277458
[TBL] [Abstract][Full Text] [Related]
13. A Non-Surgical and Cost-Effective Treatment Approach Employing Topical Imiquimod, 5-Fluorouracil, and Tretinoin for Primary Non-Melanoma Skin Cancers.
Nahm WJ; Shen J; Zito PM; Gonzalez AM; Nagrani N; Moore K; Badiavas EV; Kirsner RS; Nichols AJ
J Drugs Dermatol; 2021 Mar; 20(3):260-267. PubMed ID: 33683072
[TBL] [Abstract][Full Text] [Related]
14. Use of imiquimod 5% cream (Aldara) in cats with multicentric squamous cell carcinoma in situ: 12 cases (2002-2005).
Gill VL; Bergman PJ; Baer KE; Craft D; Leung C
Vet Comp Oncol; 2008 Mar; 6(1):55-64. PubMed ID: 19178663
[TBL] [Abstract][Full Text] [Related]
15. Sequential Treatment of Superficial Basal Cell Carcinomas With Topical Methyl Aminolevulinate Photodynamic Therapy and Imiquimod 5% Cream: A Retrospective Study of Clinical and Cosmetic Outcomes.
Logan IT; Kulakov EL; Perrett CM
Dermatol Surg; 2020 Oct; 46(10):1272-1278. PubMed ID: 32011386
[TBL] [Abstract][Full Text] [Related]
16. Combination Topical Chemotherapy for the Treatment of an Invasive Cutaneous Squamous Cell Carcinoma.
Fayne R; Nanda S; Nichols A; Shen J
J Drugs Dermatol; 2020 Feb; 19(2):202-204. PubMed ID: 32155018
[TBL] [Abstract][Full Text] [Related]
17. Squamous cell carcinoma in situ of the penis successfully treated with imiquimod 5% cream.
Schroeder TL; Sengelmann RD
J Am Acad Dermatol; 2002 Apr; 46(4):545-8. PubMed ID: 11907505
[TBL] [Abstract][Full Text] [Related]
18. Invasive squamous cell carcinoma after treatment of carcinoma in situ with 5% imiquimod cream.
Goh MS
Australas J Dermatol; 2006 Aug; 47(3):186-8. PubMed ID: 16867000
[TBL] [Abstract][Full Text] [Related]
19. Squamous cell carcinoma in situ (Bowen's disease) in renal transplant patients treated with 5% imiquimod and 5% 5-fluorouracil therapy.
Smith KJ; Germain M; Skelton H
Dermatol Surg; 2001 Jun; 27(6):561-4. PubMed ID: 11442593
[TBL] [Abstract][Full Text] [Related]
20. Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial.
Arits AH; Mosterd K; Essers BA; Spoorenberg E; Sommer A; De Rooij MJ; van Pelt HP; Quaedvlieg PJ; Krekels GA; van Neer PA; Rijzewijk JJ; van Geest AJ; Steijlen PM; Nelemans PJ; Kelleners-Smeets NW
Lancet Oncol; 2013 Jun; 14(7):647-54. PubMed ID: 23683751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
